Generate Biomedicines Q3 net loss widens 46% year over year to $87.7 million; Q3 revenue falls 56% year over year to $4.2 million

Generate Biomedicines Q3 net loss widens 46% year over year to $87.7 million; Q3 revenue falls 56% y